Table 2.
COVID-19 Clinical outcomes and metformin use.
| Metformin(n = 1021) | No Metformin(n = 3441) | p-value* | Metformin(n = 796) | No Metformin(n = 796) | p-value** | |
|---|---|---|---|---|---|---|
| In-Hospital Mortality, n (%) | 0.08 | 0.87 | ||||
| Alive | 734 (71.9) | 2569 (74.7) | 563 (70.7) | 560 (70.4) | ||
| Deceased | 287 (28.1) | 872 (25.3) | 233 (29.3) | 236 (29.6) | ||
| Length of Stay, mean (SD) | 7.3 (6.7) | 7.5 (6.7) | 0.59 | 7.7 (6.8) | 8.1 (7.1) | 0.23 |
*Comparison on original data.
**Comparison on PSM data matched on age, race, hypertension, coronary artery disease, insulin use, HbA1c, creatinine, BMI, and total number of anti-diabetic medications.